Fig. 3From: High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroidsChange from baseline in pre-dose morning FEV1 (L) [95% CI] – Post-hoc analysis - ITT populationBack to article page